$7.70
+0.07 (+0.85%)
Market Cap
$679.4M
Shares Outstanding
91,314,007
Institutional Holders
1
Total Inst. Value
$170
% of Float Held
0.0%
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | EverSource Wealth Advisors, LLC | $170 | 22 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold GYRE?
As of Q1 2025, 1 institutional investors report holding GYRE (Gyre Therapeutics, Inc.) in their 13F filings.
What percentage of Gyre Therapeutics, Inc. is owned by institutions?
Institutional investors hold approximately 0.0% of Gyre Therapeutics, Inc.'s float as reported in SEC 13F filings.
Which hedge fund owns the most GYRE?
The largest institutional holder of GYRE is EverSource Wealth Advisors, LLC with $170 in shares.
Are institutions buying or selling GYRE?
This quarter, 1 institutions opened new positions in GYRE and 1 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.